Provide freedom of movement and support ambulation abilities for as long as possible. Remember, gait is tied to procedural ...

A 30-year-old woman was evaluated because of back pain, leg stiffness, and falling. Tone was increased in the legs.

Although I am limited by ambulation issues in terms of getting out and about to attend meetings, I am doing what I can to ...

Good afternoon, and welcome to the Sarepta Therapeutics first quarter 2024 earnings call. At this time, all participants are ...

Treatment with glucocorticoids after loss of ambulation (LOA) in patients with Duchenne muscular dystrophy (DMD) can preserve late-stage functional abilities, respiratory function, and cardiac ...

Sarepta Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.37, expectations were $-0.11. Sarepta Therapeutics ...

Keynote lecture by KateTx Chief Scientific Officer and Scientific Co-founder Sharif Tabebordbar, Ph.D., features non-human primate data demonstrating best-in-class potential of KT809, a novel muscle ...

Those living with NPC lose independence due to physical and cognitive limitations, with key neurological impairments presenting in speech, cognition, swallowing, ambulation, and fine motor skills.

PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.2, expectations were $-1.31. PTC Therapeutics, Inc.

NDAQ:SRPT) Sarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate Developments ...

MINNEAPOLIS, May 02, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients suffering from fluid overload, today announced that it has ...

Study findings demonstrate the pivotal role of patient-reported outcomes in identifying frailty among individuals ...